Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran's early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hypercholesterolemia. - Landmesser U; Laufs U; Schatz U; Winzer EB; Nowak B; Kassner U; Gouni-Berthold I; Esteban A; Lubyayi L; Krueger A; Streich JH; Hentschke C; et al. (American heart journal, 2025)